UK-based clinical biotechnology company
Storm Therapeutics has raised €76M across 2 funding rounds from 10 investors, most recently a Series C round in Apr 2026. Based in Cambridge, UK; active in Healthtech. Data as of 6 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-04-16 | Series C | €48M | Fast Track Initiative (FTI),IP Group PLC,M Ventures,Pfizer Ventures,Taiho Ventures LLC,UTokyo Innovation Platform Co. | View deal → |
| 2022-12-14 | Series B | €28M | Cambridge Innovation Capital,Fast Track Initiative,IP Group PLC,M Ventures,Pfizer Ventures,Seroba Life Sciences+2 more | View deal → |
